Skip to main content
. 2008 Mar 12;99(5):1008–1015. doi: 10.1111/j.1349-7006.2008.00788.x

Figure 6.

Figure 6

In vivo antitumor effect of hsc70 fusion proteins against MO5. C57BL/6 mice were vaccinated intraperitoneally with 10 µg of each hsc70 fusion protein as indicated on days 0 and 7. Mice were challenged with MO5 at day 0 and tumor growth was monitored (n = 5).